ID1 and rheumatoid arthritis: In contrast, the administration of anti‐Adalimumab Id Ab injection did not affect the score of pro‐Adalimumab‐treated mice, demonstrating that pro‐Adalimumab can prevent the interference of anti‐Adalimumab Id Ab in vivo, thereby reducing RA progression.